Riskpilot← Back to searchSign inGet full accessJ Val Medical AB
ABActiveOrg 5592277965Sågargatan 2 DMedical specialists activities · NACE 8622Est. 20191 employees
Revenue 2024
SEK 2,6M
-6% vs 2023
EBITDA margin
32.5%
-21% vs 2023
Equity ratio
75.2%
Financial strength
Net profit 2024
SEK 622K
-21% vs 2023
| Revenue | SEK 2,6M | -6% |
| EBITDA | SEK 844K | -21% |
| Net profit | SEK 622K | -21% |
| Total assets | SEK 2,9M | +34% |
| Equity | SEK 2,2M | +40% |
| Employees | 1 | — |
Legal name
J Val Medical AB
Org number
5592277965
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 november 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom anestesi och intensivvård, utbildning och därmed förenlig verksamhet.
Address
Sågargatan 2 D
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 520 | 519 | 2 716 | 2 762 | 2 596 |
| Staff expenses | — | — | −1 345 | −1 358 | — |
| EBITDA | 345 | 429 | 1 044 | 1 068 | 844 |
| Depreciation & amort. | −0 | −32 | −73 | −73 | −66 |
| EBIT | 345 | 397 | 971 | 995 | 778 |
| Net financials | — | — | −0 | 3 | 6 |
| Profit before tax | 346 | 307 | 771 | 998 | 784 |
| Tax | −74 | −63 | −159 | −206 | −162 |
| Net profit | 272 | 244 | 612 | 792 | 622 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 588 | 922 | 1 547 | 2 173 | 2 920 |
| Equity | 376 | 619 | 1 081 | 1 573 | 2 195 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 212 | 212 | 176 | 311 | 435 |
| Total debt | 212 | 212 | 176 | 311 | 435 |
EBITDA margin
32.5%
This company
15.8%
Market median
+106% vs market
20202024
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
28.3%
This company
18.4%
Market median
+54% vs market
20202024
Net profit margin
24.0%
This company
8.1%
Market median
+196% vs market
20202024
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of J Val Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigridur Margaretha Johannsdotter | Deputy Board Member | 0 companies |
| Håkan Johannsson | Deputy Board Member | 0 companies |
| Ewa Margareta Hjelm | Board of Directors | 0 companies |
| Johann Valtysson | Chairman | 0 companies |